Evidence map›Paper›PMID 26407009›Full record

ArticlePLoS pathogens2015

Plasmodium Infection Is Associated with Impaired Hepatic Dimethylarginine Dimethylaminohydrolase Activity and Disruption of Nitric Oxide Synthase Inhibitor/Substrate Homeostasis.

Jessica H Chertow, Matthew S Alkaitis, Glenn Nardone, Allison K Ikeda, Aubrey J Cunnington, Joseph Okebe, Augustine O Ebonyi, Madi Njie, Simon Correa, Shamanthi Jayasooriya and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Oxidative Stress in Malaria: Potential Benefits of Antioxidant Therapy.International journal of molecular sciences · 2022
    Review
  4. Article
  5. DDAH-1, via regulation of ADMA levels, protects against ischemia-induced blood-brain barrier leakage.Laboratory investigation; a journal of technical methods and pathology · 2021
    Article
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

Jessica H ChertowLaboratory of Malaria and Vector Research, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Matthew S AlkaitisLaboratory of Malaria and Vector Research, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America; Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Headington Oxford, United Kingdom.
Glenn NardoneResearch Technology Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Allison K IkedaLaboratory of Malaria and Vector Research, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Aubrey J CunningtonSection of Paediatrics, Imperial College London, London, United Kingdom.
Joseph OkebeMRC Unit, Fajara, The Gambia.
Augustine O EbonyiMRC Unit, Fajara, The Gambia.
Madi NjieMRC Unit, Fajara, The Gambia.
Simon CorreaMRC Unit, Fajara, The Gambia.
Shamanthi JayasooriyaMRC Unit, Fajara, The Gambia.
Climent Casals-PascualWellcome Trust Centre for Human Genetics, Oxford, United Kingdom.
Oliver BillkerWellcome Trust Sanger Institute, Hinxton Cambridge, United Kingdom.
David J ConwayMRC Unit, Fajara, The Gambia; London School of Hygiene and Tropical Medicine, Bloomsbury, London, United Kingdom.
Michael WaltherMRC Unit, Fajara, The Gambia.
Hans AckermanLaboratory of Malaria and Vector Research, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
MRC Unit the Gambia · GMNational Institute of Allergy and Infectious Diseases · USCentre for Human Genetics · GBImperial College London · GBLondon School of Hygiene & Tropical Medicine · GBNational Institutes of Health · USUniversity of Oxford · GBWellcome Sanger Institute · GB

Funding

Nitric Oxide and Endothelial Function in Patients with MalariaZIAAI001150 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI ACKERMAN, HANS · 2011 to 2025
$19.4M
Genetic Factors that Alter Vascular Function in Sickle Cell DiseaseZIAHL006196 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ACKERMAN, HANS · 2015 to 2017
$6.2M
Medical Research Council G0701427Medical Research Council MR/L006529/1Wellcome TrustWellcome Trust WT098051
6 · The paper itself

Abstract

Inhibition of nitric oxide (NO) signaling may contribute to pathological activation of the vascular endothelium during severe malaria infection. Dimethylarginine dimethylaminohydrolase (DDAH) regulates endothelial NO synthesis by maintaining homeostasis between asymmetric dimethylarginine (ADMA), an endogenous NO synthase (NOS) inhibitor, and arginine, the NOS substrate. We carried out a community-based case-control study of Gambian children to determine whether ADMA and arginine homeostasis is disrupted during severe or uncomplicated malaria infections. Circulating plasma levels of ADMA and arginine were determined at initial presentation and 28 days later. Plasma ADMA/arginine ratios were elevated in children with acute severe malaria compared to 28-day follow-up values and compared to children with uncomplicated malaria or healthy children (p<0.0001 for each comparison). To test the hypothesis that DDAH1 is inactivated during Plasmodium infection, we examined DDAH1 in a mouse model of severe malaria. Plasmodium berghei ANKA infection inactivated hepatic DDAH1 via a post-transcriptional mechanism as evidenced by stable mRNA transcript number, decreased DDAH1 protein concentration, decreased enzyme activity, elevated tissue ADMA, elevated ADMA/arginine ratio in plasma, and decreased whole blood nitrite concentration. Loss of hepatic DDAH1 activity and disruption of ADMA/arginine homeostasis may contribute to severe malaria pathogenesis by inhibiting NO synthesis.

Indexed as

AmidohydrolasesAnimalsArginineCase-Control StudiesDisease Models, AnimalEndothelium, VascularGambiaHomeostasisHumansLiverMalariaMiceNitric OxideAmidohydrolasesArgininedimethylargininaseNitric Oxide

Identifiers

PMID26407009
PMCPMC4583463
OpenAlexW1846977275

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.